Perceptions and experiences of lifestyle interventions in women with polycystic ovary syndrome (PCOS), as a management strategy for symptoms of PCOS. Arentz, S., Smith, C.A., Abbott, J. et al. BMC Women’s Health 21, 107 (2021). The international clinical practice guidelines for PCOS emphasize diet and exercise as first-line management of clinical signs and symptoms. This study aimed to...
Poz.com, January 21, 2021 On January 21, the Food and Drug Administration (FDA) in the USA approved the first complete injectable HIV treatment regimen that does not require daily pills. Cabenuva, from ViiV Healthcare, is administered only once a month. It is approved for people with an undetectable viral load on their current therapy who wish to switch to a long-acting regimen. Cabenuva consists...
Priorities for preventing a concentrated HIV epidemic among Aboriginal and Torres Strait Islander Australians James S Ward, Karen Hawke and Rebecca J Guy Med J Aust 2018; 209 (1): 56. || doi: 10.5694/mja17.01071 Published online: 2 July 2018 Greater efforts are required to prevent human immunodeficiency virus infection (HIV) escalating among Aboriginal and Torres Strait Islander Australians...
BMC Public Health Published: 2 February 2018 Abstract: Background The New South Wales (NSW) HIV Strategy 2016–2020 aims for the virtual elimination of HIV transmission in NSW, Australia, by 2020. Despite high and increasing levels of HIV testing and treatment since 2012, the annual number of HIV diagnoses in NSW has remained generally unchanged. Pre-exposure prophylaxis (PrEP) is highly...
JAMA Internal Medicine, 2017 Transdermal estrogen therapy delivered through the skin modestly improved sexual function in early postmenopausal women, according to an article published by JAMA Internal Medicine. Declining estrogen levels around the menopausal transition are commonly associated with sexual dysfunction, which can be an important determinant of women’s health and quality of life. In...
Journal of Virus Eradication, 2017; 3: 168–184 Daily use of co-formulated tenofovir and emtricitabine for HIV pre-exposure prophylaxis (PrEP) by populations at high risk of HIV infection is now recommended in guidelines from the United States, Europe and Australia and globally through the 2015 WHO guidelines. These 2017 Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine‘s...